Volume 24, Number 9—September 2018
Dispatch
Maripa Virus RNA Load and Antibody Response in Hantavirus Pulmonary Syndrome, French Guiana
Table 2
Monitoring of hantavirus antibodies and viral RNA load in sequential serum samples from patient 6, French Guiana*
Characteristic |
Days after symptom onset |
||||||
Day 7 |
Day 12 |
Day 15 |
Day 20 |
Day 25 |
Day 30 |
Day 46 |
|
SNV IgM |
Positive |
Positive |
Positive |
Positive |
Positive |
Positive |
Negative |
IgM sum OD† |
1.79 |
1.56 |
1.50 |
1.34 |
1.01 |
0.72 |
0.42 |
SNV IgG |
Negative |
Positive |
Positive |
Positive |
Positive |
Positive |
Positive |
IgG sum OD† |
0.73 |
1.83 |
2.20 |
3.08 |
4.21 |
4.71 |
4.40 |
Serum viral RNA load‡ | 6.4 | 5.4 | 4.7 | 4.1 | 4.0 | 4.1 | 0 |
*OD, optical density; SNV, Sin Nombre virus.
†Adjusted sum OD values (dilution 1:100, 1:400, 1:1,600, and 1:6,400).
‡Virus copy number was determined as logs10 copies/mL. real-time PCR Primers and TaqMan probe for quantitative PCR were Maripa_qRT2F 5'-GCAGCTGTGTCTACATTGGAGAA-3', Maripa_qRT2R 5'-CCACCAGATCCGCCAACT-3', and Maripa_Probe2 5'-FAM-AAACTTGCAGAACTCA-MGB-3'.
Page created: August 15, 2018
Page updated: August 15, 2018
Page reviewed: August 15, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.